Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfacalcidol on Falls in Elderly Postmenopausal Osteopenic/Osteoporotic Women
NCT00168909Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jun 2003
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in osteoporosis, osteopenia and falls comparing alfacalcidol 1µg/d with placebo (2 arms). Primary endpoint: Number of fallers (patients with at least one locomotor fall incl.mixed falls) at 3 years. Started Jun 2003; status: completed.
02
Drugs
alfacalcidol
03
Conditions
osteoporosisosteopeniafalls
Beyond the preview
Go deeper on NCT00168909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168909.